Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings?

Zacks.....»»

Gilead Sciences (NASDAQ: GILD) reported quarterly earnings of $1.68 per share on Thursday, which beat the analyst consensus estimate of $1.57 by 7.01%. This is a 4.55% decrease over earnings of $1.76 per share from the same period last year. read more.....»»

U.S. railroad operator Kansas City Southern withdrew its full-year earnings forecast on Friday on coronavirus concerns, but topped Wall Street estimates for quarterly profit as higher Mexico shipments boosted sales its chemicals and petroleum business......»»

Intel Corp. shares rallied in the extended session Thursday after the chip maker’s quarterly results and outlook topped Wall Street estimates with a big beat in data-center sales......»»

Gilead Science Inc. shares dropped about 2.5% in the extended session Thursday, after the drug maker beat Wall Street’s earnings expectations but reported lower-than-expected sales......»»

General Motors stuck to its upbeat earnings forecast, defying a global industry slowdown with strong sales of pickup trucks in North America. Fred Katayama reports......»»

General Motors Co posted a better-than-expected net profit on Thursday as high-margin pickup trucks, SUVs and crossovers helped overcome slowing sales in the United States and China, and reiterated its full-year earnings forecast......»»

General Motors Co posted a better-than-expected net profit on Thursday as high-margin pickup trucks, SUVs and crossovers helped overcome slowing sales in the United States and China, and reiterated its full-year earnings forecast......»»

Gilead Sciences, Inc. (NASDAQ: GILD) shares are slightly higher after reporting a second-quarter earnings beat. read more.....»»

Gilead Sciences Inc. reported a surprising gain in revenue Tuesday afternoon and beat earnings expectations, sending shares about 2% higher in after-hours trading......»»

PepsiCo (PEP) beats earnings and sales estimates in second-quarter 2019. Results gain from strength in all of it.....»»

Growth in Walgreens Boots Alliance Inc.’s U.S. retail pharmacy business helped drive an increase in sales in the third quarter, but the drugstore chain still faces some significant challenges......»»

Pfizer Inc on Tuesday reported first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company reined in costs and recorded higher sales of blood thinner Eliquis and Prevnar pneumonia vaccine......»»

Higher sales volumes for aircraft carriers and navy nuclear support services are expected to drive revenues for Huntington Ingalls' (HII) Newpoer News segment in.....»»

AstraZeneca (AZN) beats earnings and sales estimates in the first quarter. New drugs, especial.....»»

While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericizati.....»»

Shoe Carnival Inc. shares soared 19.3% in early Wednesday trading after the retailer reported a fourth-quarter earnings beat and same-store sales growth of 4.7%, blowing past the 3.8% FactSet consensus. "As expected, women's boots were the key drive.....»»

Gilead (GILD) is likely to beat earnings estimates when it reports fi.....»»

Roche (RHHBY) beat sales estimates in the first quarter driven by strong performance of Oc.....»»

Gilead (GILD) is likely to report an earnings beat in the first-quarter (results due on May 1) driven by its HIV franchise strength. Biotech bigwig Gilead Sciences Inc. GILD develops drugs for the treatment of human immu.....»»